Detalhe da pesquisa
1.
In vitro activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against Mycobacterium abscessus.
Antimicrob Agents Chemother
; 68(5): e0017424, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557171
2.
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
J Antimicrob Chemother
; 78(12): 2849-2858, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864515
3.
Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
Am J Respir Crit Care Med
; 205(9): 1064-1074, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085056
4.
Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity.
Bioorg Med Chem
; 25(14): 3746-3755, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28545813
5.
Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design.
PLoS One
; 18(12): e0291910, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117792
6.
Molecular Epidemiologic Investigation of Mycobacterium intracellulare Subspecies chimaera Lung Infections at an Adult Cystic Fibrosis Program.
Ann Am Thorac Soc
; 20(5): 677-686, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656594
7.
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections.
Front Microbiol
; 9: 1547, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042757
8.
Gene replacement in Mycobacterium chelonae: application to the construction of porin knock-out mutants.
PLoS One
; 9(4): e94951, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739882